KEY HIGHLIGHTS
- PATMI surged 225% YoY to IDR 1.68Tn in 1H26 (2Q26 +111% QoQ to IDR 1.14Tn), already exceeding full-year 2025 earnings and ~129% of FY26F consensus; upgrades look likely.
- Revenue +84% YoY to IDR 2.20Tn, almost entirely commercial land-plot handovers in CBD PIK2 of IDR 1.97Tn (89% of revenue, +273% YoY). Gross margin rose to 84% from 61%, EBITDA margin to 74%.
- New pre-sales are soft, the key watch item: marketing sales fell 22% YoY to IDR 231.0Bn in 1H26 (41% of the IDR 563Bn target), land plots -32% YoY. The earnings surge is handover-driven (recognising backlog), so forward momentum hinges on reviving new land-plot demand.
- Net cash balance sheet, LTM ROE 18.8%. CBDK trades at 2.0x P/BV vs its 1-year mean of 3.6x. Watch the NICE convention-centre recurring-income ramp and CBD PIK2 landmarks (Bank Mandiri, BNI).
Regards, Aldiracita Research